INFLAMMATORY RHEUMATIC DISEASES - REVIEW OF 4734 PATIENTS TREATED WITH ACEMETACIN

被引：0
|
作者：
DULLENKOPF, B
机构：
来源：
MEDIZINISCHE WELT | 1992年 / 43卷 / 02期
关键词：
ACEMETACIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NSAIDS; RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; ANKYLOSING SPONDYLITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nonsteroidal antiinflammatory drugs (NSAID) are of considerable importance in the long-term treatment of inflammatory rheumatic diseases. They limit inflammation and reduce pain and thus allow for physiotherapy essential for long-term prognosis. This review summarizes the results of treatment with the indolacetic acid derivative acemetacin in 4734 patients suffering from inflammatory rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. In all of these studies acemetacin showed marked antiinflammatory and analgetic activity which equaled or surpassed that of other NSAID. In most cases, adverse reactions occurred less frequently and were less pronounced with acemetacin.
引用
收藏
页码：191 / 197
页数：7
相关论文
共 50 条
  • [1] TREATMENT OF INFLAMMATORY RHEUMATIC DISEASES WITH ACEMETACIN AND INDOMETHACIN
    THEBUDLASSAK, R
    DULLENKOPF, B
    RECHZIEGLER, H
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 1988, 47 (04): : 289 - 290
  • [2] THERAPY OF INFLAMMATORY RHEUMATIC JOINT DISEASES WITH ACEMETACIN AND INDOMETHACIN
    THEBUDLASSAK, R
    BERNARD, I
    HEININGER, K
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 176 - 176
  • [3] Outcome of patients with inflammatory rheumatic diseases treated in an integrative concept
    Alten, RHE
    Bleneck, S
    Pohl, C
    Schmidt, H
    Pietsch, C
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 360 - 360
  • [4] ACEMETACIN IN THE TREATMENT OF RHEUMATIC DISEASES - AN OPEN, MULTICENTER TRIAL
    RECHZIEGLER, H
    ZUNDORF, P
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1985, 9 (10) : 701 - 707
  • [5] COVID-19 IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES
    Hasseli, R.
    Hoyer, B. F.
    Lorenz, H. M.
    Pfeil, A.
    Regierer, A.
    Richter, J.
    Schmeiser, T.
    Strangfeld, A.
    Voll, R.
    Schulze-Koops, H.
    Krause, A.
    Specker, C.
    Mueller-Ladner, U.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 957 - 957
  • [6] COVID-19 in Rituximab treated patients with inflammatory rheumatic diseases
    Haesseli-Frabel, Rebecca
    Hoyer, Bimba Franziska
    Lorenz, Hanns-Martin
    Pfeil, Alexander
    Regierer, Anne C.
    Richter, Jutta G.
    Schmeiser, Tim
    Strangfeld, Anja
    Voll, Reinhard E.
    Schulze-Kops, Hendrik
    Krause, Andreas
    Specker, Christof
    Mueler-Ladner, Ulf
    [J]. INTERNIST, 2022, 63 (SUPPL 3): : 360 - 360
  • [7] The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitors
    Rybar, I
    Rozborilova, E.
    Zanova, E.
    Micekova, D.
    Sojovic, I
    Rovensky, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (04): : 164 - 167
  • [8] Immunization in patients with inflammatory rheumatic diseases
    Thomas, Konstantinos
    Vassilopoulos, Dimitrios
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (05): : 946 - 963
  • [9] Cryotherapy in inflammatory rheumatic diseases: a systematic review
    Guillot, Xavier
    Tordi, Nicolas
    Mourot, Laurent
    Demougeot, Celine
    Dugue, Benoit
    Prati, Clement
    Wendling, Daniel
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (02) : 281 - 294
  • [10] Teriparatide treatment in osteoporotic patients treated with glucocorticoids for chronic inflammatory/autoimmune rheumatic diseases
    La Corte, R.
    Limpido, G.
    Volpinari, S.
    Trotta, F.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S324 - S324
12345